Specialty Pharmacy Will Gain a Bigger Chunk of U.S. Pharmaceuticals – APhA submits compounding comments to FDA.

14738_graphic_standard_070616Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Specialty Pharmacy Will Gain a Bigger Chunk of U.S. Pharmaceuticals – APhA submits compounding comments to FDA. – (866) 348-2889

The specialty pharmacy market will continue to gain ground within the overall pharmaceutical market, according to a report from the HDA Research Foundation. In 2016, specialty pharmacy was 40% of the $450 billion pharmaceutical market, compared to 30% of the $318 billion market in 2012. Specialty sales in 2016 rose 11% over 2015 sales, to $181 billion.

Although the report does not focus on future sales or predict trends, this growth in market segment is expected to continue. “In our experience, I think you definitely see a growth in the industry being driven by specialty products,” said Perry Fri, Executive Vice President for Industry Relations, Membership and Education at the Healthcare Distribution Alliance (HDA) and Chief Operating Officer for the HDA Research Foundation. “We know that growth is being driven by more medicines in this category, and more patients eligible to use those medicines.”


This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.